ET-3 sensitive reduction of tissue blood flow in rat liver. 1992

T Kurihara, and M Akimoto, and K Kurokawa, and H Ishiguro, and A Niimi, and A Maeda, and M Sigemoto, and K Yamashita, and I Yokoyama, and Y Hirayama
Institute of Geriatrics, Tokyo Women's Medical College, Japan.

Changes in gastric mucosal and hepatic tissue blood flow were simultaneously determined using a laser-Doppler blood flow meter in rats given i.v. injection of endothelin-1 (ET-1) and endothelin-3 (ET-3), both at 2 nmol/kg. Gastric mucosal blood flow decreased significantly after administration of ET-1 compared to after administration of ET-3. Decreases in blood flow due to ET-1 were reversed by pre-treatment with 10 mg/kg of BQ-123 (sodium salt), an ETA receptor antagonist, to levels comparable to those induced by ET-3, but BQ-123 had no effects on decreases in blood flow due to ET-3. On the other hand, decreases in hepatic tissue blood flow by ET-3 were significant compared to those by ET-1. Decreases in hepatic tissue blood flow due to ET-1 were slightly inhibited by pre-treatment with 10 mg/kg of BQ-123, but it had no effect at all on decreases due to ET-3. These findings indicate that decreases in gastric mucosal blood flow are mainly caused by ET-1 via ETA receptors inhibited by BQ-123, while decreases in hepatic tissue blood flow are caused mainly by ET-3 via non-ETA receptors not inhibited by BQ-123. The fact that ET-3 decreases blood flow more significantly than ET-1 suggests the involvement of ET-3 selective receptors (ETc). The findings obtained in the present study indicate that complex mechanisms are involved in the regulation of tissue blood flow by ET, with different receptor subtypes and ET family peptides being involved according to the type of tissue.

UI MeSH Term Description Entries
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D008297 Male Males
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016232 Endothelins 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides. Endothelium-Derived Vasoconstrictor Factors,Endothelin,Vasoconstrictor Factors, Endothelium-Derived
D017466 Receptors, Endothelin Cell surface proteins that bind ENDOTHELINS with high affinity and trigger intracellular changes which influence the behavior of cells. Endothelin Receptors,Receptors, Endothelium-Derived Vasoconstrictor Factor,Endothelin Receptor,Endothelium Derived Vasoconstrictor Factor Receptors,Receptors, Endothelins,Receptor, Endothelin,Receptors, Endothelium Derived Vasoconstrictor Factor

Related Publications

T Kurihara, and M Akimoto, and K Kurokawa, and H Ishiguro, and A Niimi, and A Maeda, and M Sigemoto, and K Yamashita, and I Yokoyama, and Y Hirayama
July 1981, The New England journal of medicine,
T Kurihara, and M Akimoto, and K Kurokawa, and H Ishiguro, and A Niimi, and A Maeda, and M Sigemoto, and K Yamashita, and I Yokoyama, and Y Hirayama
June 1953, The Journal of physiology,
T Kurihara, and M Akimoto, and K Kurokawa, and H Ishiguro, and A Niimi, and A Maeda, and M Sigemoto, and K Yamashita, and I Yokoyama, and Y Hirayama
August 1994, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
T Kurihara, and M Akimoto, and K Kurokawa, and H Ishiguro, and A Niimi, and A Maeda, and M Sigemoto, and K Yamashita, and I Yokoyama, and Y Hirayama
February 2014, Academic radiology,
T Kurihara, and M Akimoto, and K Kurokawa, and H Ishiguro, and A Niimi, and A Maeda, and M Sigemoto, and K Yamashita, and I Yokoyama, and Y Hirayama
March 1954, The Journal of physiology,
T Kurihara, and M Akimoto, and K Kurokawa, and H Ishiguro, and A Niimi, and A Maeda, and M Sigemoto, and K Yamashita, and I Yokoyama, and Y Hirayama
May 1995, Diseases of the colon and rectum,
T Kurihara, and M Akimoto, and K Kurokawa, and H Ishiguro, and A Niimi, and A Maeda, and M Sigemoto, and K Yamashita, and I Yokoyama, and Y Hirayama
May 1995, Hypertension (Dallas, Tex. : 1979),
T Kurihara, and M Akimoto, and K Kurokawa, and H Ishiguro, and A Niimi, and A Maeda, and M Sigemoto, and K Yamashita, and I Yokoyama, and Y Hirayama
March 1981, The New England journal of medicine,
T Kurihara, and M Akimoto, and K Kurokawa, and H Ishiguro, and A Niimi, and A Maeda, and M Sigemoto, and K Yamashita, and I Yokoyama, and Y Hirayama
December 1997, Osaka city medical journal,
T Kurihara, and M Akimoto, and K Kurokawa, and H Ishiguro, and A Niimi, and A Maeda, and M Sigemoto, and K Yamashita, and I Yokoyama, and Y Hirayama
January 1986, Intensive care medicine,
Copied contents to your clipboard!